These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11260285)

  • 1. Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa.
    Sheth S; Dimichele D; Lee M; Lamour J; Quaegebeur J; Hsu D; Addonizio L; Piomelli S
    Haemophilia; 2001 Mar; 7(2):227-32. PubMed ID: 11260285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
    Livnat T; Martinowitz U; Azar-Avivi S; Zivelin A; Brutman-Barazani T; Lubetsky A; Kenet G
    Haemophilia; 2013 Sep; 19(5):782-9. PubMed ID: 23659442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor.
    Croteau SE; Abajas YL; Wolberg AS; Nielsen BI; Marx GR; Baird CW; Neufeld EJ; Monahan PE
    Haemophilia; 2017 Mar; 23(2):e93-e98. PubMed ID: 28124406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.
    Tagariello G; De Biasi E; Gajo GB; Risato R; Radossi P; Davoli PG; Traldi A
    Haemophilia; 2000 Sep; 6(5):581-3. PubMed ID: 11012706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rVIIa therapy to secure haemostasis during central line insertion in children with high-responding FVIII inhibitors.
    Smith OP; Hann IM
    Br J Haematol; 1996 Mar; 92(4):1002-4. PubMed ID: 8616058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor.
    Perez R; Martinez RL; Piñero A; Sosa R
    Haemophilia; 2002 Nov; 8(6):822-5. PubMed ID: 12410655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitors.
    Saba HI; Morelli GA; Azam RR; Klein CJ; Letson GD
    Haemophilia; 2003 Jan; 9(1):131-6. PubMed ID: 12558792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery in haemophilic patients with inhibitor: 20 years of experience.
    Quintana-Molina M; Martínez-Bahamonde F; González-García E; Romero-Garrido J; Villar-Camacho A; Jiménez-Yuste V; Fernández-Bello I; Hernández-Navarro F
    Haemophilia; 2004 Sep; 10 Suppl 2():30-40. PubMed ID: 15385044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor.
    Stewart AJ; Hanley JP; Ludlam CA
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S93-5. PubMed ID: 9819036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.
    Klintman J; Astermark J; Berntorp E
    Br J Haematol; 2010 Nov; 151(4):381-6. PubMed ID: 20977448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major surgery for a gastric cancer in a haemophilic with high inhibitor titre successfully performed by the use of recombinant FVIIa.
    Rocino A; Carola A; Papa ML; Parisi V; Cremona F; Miraglia E; De Biasi R
    Haemophilia; 1999 Nov; 5(6):441-4. PubMed ID: 10583533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor.
    Hayashi T; Tanaka I; Shima M; Yoshida K; Fukuda K; Sakurai Y; Matsumoto T; Giddings JC; Yoshioka A
    Haemophilia; 2004 Jul; 10(4):397-400. PubMed ID: 15230956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
    Qi X; Zhao Y; Li K; Fan L; Hua B
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):754-60. PubMed ID: 24806320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
    Valentino LA; Cooper DL; Goldstein B
    Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience.
    Habermann B; Hochmuth K; Hovy L; Scharrer I; Kurth AH
    Haemophilia; 2004 Nov; 10(6):705-12. PubMed ID: 15569165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.
    Rea CJ; Foley JH; Bevan DH; Sørensen B
    Ann Hematol; 2014 Apr; 93(4):683-92. PubMed ID: 24193375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
    Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ
    Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors in haemophilia A: current management and open issues.
    Haya S; Moret A; Cid AR; Cortina V; Casaña P; Cabrera N; Aznar JA
    Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.